Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Single-cell profiling of tumour evolution in multiple myeloma — opportunities for precision medicine
Ankit K. Dutta, Jean-Baptiste Alberge, Romanos Sklavenitis‐Pistofidis, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 4, pp. 223-236
Closed Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Multiple myeloma with high-risk cytogenetics and its treatment approach
Ichiro Hanamura
International Journal of Hematology (2022) Vol. 115, Iss. 6, pp. 762-777
Open Access | Times Cited: 73
Exploring cellular diversity in lung adenocarcinoma epithelium: Advancing prognostic methods and immunotherapeutic strategies
Lianmin Zhang, Yanan Cui, Jie Mei, et al.
Cell Proliferation (2024) Vol. 57, Iss. 11
Open Access | Times Cited: 26
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma
Michael Rade, Nora Grieb, R. Weiß, et al.
Nature Cancer (2024) Vol. 5, Iss. 9, pp. 1318-1333
Open Access | Times Cited: 16
Emerging digital PCR technology in precision medicine
Lexiang Zhang, Rokshana Parvin, Qihui Fan, et al.
Biosensors and Bioelectronics (2022) Vol. 211, pp. 114344-114344
Closed Access | Times Cited: 67
Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence
Kristine Misund, Davine Hofste op Bruinink, Eivind Coward, et al.
Leukemia (2022) Vol. 36, Iss. 7, pp. 1887-1897
Open Access | Times Cited: 45
Single cell characterization of myeloma and its precursor conditions reveals transcriptional signatures of early tumorigenesis
Rebecca Boiarsky, Nicholas J. Haradhvala, Jean-Baptiste Alberge, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 40
Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis
Alexandra M. Poos, Nina Prokoph, Moritz J. Przybilla, et al.
Blood (2023) Vol. 142, Iss. 19, pp. 1633-1646
Open Access | Times Cited: 32
Functional cure and long-term survival in multiple myeloma: how to challenge the previously impossible
Monika Engelhardt, K. Martin Kortüm, Hartmut Goldschmidt, et al.
Haematologica (2024)
Open Access | Times Cited: 14
Integrating machine learning and single‐cell analysis to uncover lung adenocarcinoma progression and prognostic biomarkers
Pengpeng Zhang, Jiaqi Feng, Rui Min, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 13
Open Access | Times Cited: 10
Maraviroc enhances Bortezomib sensitivity in multiple myeloma by inhibiting M2 macrophage polarization via PI3K/AKT/RhoA signaling pathway in macrophages
Huiye Yang, Yuchan He, Fujun Qu, et al.
Cell Division (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Advancements and applications of single-cell multi-omics techniques in cancer research: Unveiling heterogeneity and paving the way for precision therapeutics
Anqi Liang, Ying Kong, Zhi Hong Chen, et al.
Biochemistry and Biophysics Reports (2023) Vol. 37, pp. 101589-101589
Open Access | Times Cited: 22
Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level
Lukas John, Alexandra M. Poos, Alexander Brobeil, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 21
Self-supervised deep clustering of single-cell RNA-seq data to hierarchically detect rare cell populations
Tianyuan Lei, Ruoyu Chen, Shaoqiang Zhang, et al.
Briefings in Bioinformatics (2023) Vol. 24, Iss. 6
Open Access | Times Cited: 17
Deciphering lung adenocarcinoma prognosis and immunotherapy response through an AI‐driven stemness‐related gene signature
Bicheng Ye, Ge Hongting, Wen Zhuang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 14
Open Access | Times Cited: 8
Microfluidic platform for omics analysis on single cells with diverse morphology and size: A review
Shujing Lin, Dan Feng, Xiao Han, et al.
Analytica Chimica Acta (2024) Vol. 1294, pp. 342217-342217
Closed Access | Times Cited: 6
Genomic instability and genetic heterogeneity in aging: insights from clonal hematopoiesis (CHIP), monoclonal gammopathy (MGUS), and monoclonal B-cell lymphocytosis (MBL)
Attila Kállai, Zoltán Ungvári, Mónika Fekete, et al.
GeroScience (2024)
Open Access | Times Cited: 5
Hotspots and trends in multiple myeloma bone diseases: A bibliometric visualization analysis
Zhaomeng Hou, Ping Jiang, Shaoting Su, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
Dynamic single-cell RNA-seq analysis reveals distinct tumor program associated with microenvironmental remodeling and drug sensitivity in multiple myeloma
Mengping Chen, Yike Wan, Xin Li, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Integrated Single-Cell Sequencing for the Development of a Gja4-Based Precision Immuno-Prognostic Model in Melanoma
Yantao Ding, Shengxiu Liu, Zaixing Wang, et al.
(2025)
Closed Access
Development Trends in the Clinical Test of Multiple Myeloma from 2000 to 2023: A Bibliometric Study
Hongcheng Wu, Haomiao Sun, Yichen Wang, et al.
(2025)
Closed Access
GDF15-mediated enhancement of the Warburg effect sustains multiple myeloma growth via TGFβ signaling pathway
Wenjing Xue, Ying Li, Ye Ma, et al.
Cancer & Metabolism (2025) Vol. 13, Iss. 1
Open Access
Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts
Mattia D’Agostino, Marina Martello, Lorenzo De Paoli, et al.
Annals of Hematology (2025)
Open Access
Exploring Single-Probe Single-Cell Mass Spectrometry: Current Trends and Future Directions
Deepti Bhusal, Shakya Wije Munige, Zongkai Peng, et al.
Analytical Chemistry (2025)
Closed Access
Quantifying and interpreting biologically meaningful spatial signatures within tumor microenvironments
Siyu Jing, He-qi Wang, Ping Lin, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Clinicians’ Perspectives and Methodological Application of Fluorescence in Situ Hybridization (FISH) to Define Cytogenetic Risk in Multiple Myeloma: An Italian, Real-World, Survey-Based Report from the European Myeloma Network (EMN) Italy
Lorenzo Cani, Maria Teresa Petrucci, Katia Mancuso, et al.
Clinical Lymphoma Myeloma & Leukemia (2025)
Open Access
Page 1 - Next Page

Scroll to top